KO‘KRAK SARATONINI DAVOLASHDA NEOADYUVANT KIMYOTERAPIYANING SAMARADORLIGINI BAHOLASH
Keywords:
ko‘krak saratoni, neoadyuvant kimyoterapiya, retrospektiv tahlil, patologik to‘liq javob, RECIST 1.1, organ saqlovchi jarrohlik, davolash samaradorligi.Abstract
Ko‘krak saratoni ayollar orasida eng ko‘p uchraydigan xavfli o‘smalardan biri bo‘lib, uni davolashda neoadyuvant kimyoterapiya muhim o‘rin tutadi. Mazkur tadqiqotning maqsadi bir klinikada ko‘krak saratoni bilan davolangan bemorlarda neoadyuvant kimyoterapiya samaradorligini retrospektiv baholashdan iborat. Tadqiqotga 2021–2024-yillar davomida morfologik tasdiqlangan ko‘krak saratoni tashxisi bilan neoadyuvant kimyoterapiya olgan bemorlarning tibbiy hujjatlari kiritildi. Davolash samaradorligi RECIST 1.1 mezonlari, patologik to‘liq javob (pCR), bajarilgan jarrohlik amaliyoti turi hamda davolash bilan bog‘liq nojo‘ya holatlar asosida baholandi. Retrospektiv tahlil natijasida neoadyuvant kimyoterapiya o‘smalar hajmini sezilarli darajada kamaytirishi, patologik to‘liq javobga erishish ko‘rsatkichlarini oshirishi va organ saqlovchi jarrohlik amaliyotlarini ko‘paytirishi aniqlandi. Davolashning nojo‘ya ta'sirlari asosan boshqariladigan darajada kuzatildi. Olingan natijalar neoadyuvant kimyoterapiyaning ko‘krak saratonini kompleks davolashdagi samarali usullardan biri ekanligini tasdiqlaydi.
References
American Society of Clinical Oncology. Neoadjuvant Chemotherapy in Breast Cancer: ASCO Guideline. 2024.
Cortazar P., et al. Pathological complete response and long-term clinical benefit in breast cancer. Lancet. 2014.
European Society for Medical Oncology. ESMO Clinical Practice Guidelines for Breast Cancer. 2023.
International Agency for Research on Cancer. Global Cancer Observatory (GLOBOCAN). 2024.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 2025.
von Minckwitz G., et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy. Journal of Clinical Oncology. 2012.
World Health Organization. Breast Cancer: Global Statistics and Management. Geneva; 2024.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo